BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹111 Cr | ₹56 Cr | ₹52 Cr | ₹28 Cr | ₹77 Cr |
What is the latest Sundry Debtors ratio of BALAXI PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹28 Cr |
| Mar2021 | ₹77 Cr |
How is Sundry Debtors of BALAXI PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹111 Cr | 98.90 | |
| Mar2024 | ₹56 Cr | 6.55 | |
| Mar2023 | ₹52 Cr | 89.71 | |
| Mar2022 | ₹28 Cr | -64.10 | |
| Mar2021 | ₹77 Cr | - | |
Compare Sundry Debtors of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹104.2 Cr | -5.7% | -22.7% | -65.1% | Stock Analytics | |
| ADANI ENTERPRISES | ₹274,469.0 Cr | -2.7% | 9.3% | 5.6% | Stock Analytics | |
| REDINGTON | ₹20,545.0 Cr | 9.5% | -1.4% | 12% | Stock Analytics | |
| HONASA CONSUMER | ₹9,530.1 Cr | -4.2% | 5.6% | 35.7% | Stock Analytics | |
| MMTC | ₹8,791.5 Cr | -4.9% | -7.1% | 12.7% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,576.3 Cr | -8.1% | -11.4% | 18% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -5.7% |
-22.7% |
-65.1% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses